Riddy, D
Compounded Medication Concerns Compounded GLP-1 medications are not approved by the FDA for safety or efficacy
For healthcare systems and policymakers, the evidence supports cautious optimism tempered by realistic acknowledgment of current limitations and the need for comprehensive approaches that address pharmacological efficacy, access, sustainability, and equity concerns
Nuts and seeds can also contribute some protein, but they are best viewed as a complement rather than a primary source
Wegovy specifically for weight management), dulaglutide (Trulicity), liraglutide (Victoza for diabetes, Saxenda for weight management), and exenatide (Byetta, Bydureon), though availability may vary
Studies have shown that certain beneficial gut bacteria can influence GLP-1 production